Scarica l'app Stockscreener
243.92
1.69%
4.0237
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WST Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$239.90
Aprire:
$240.71
Volume 24 ore:
182.58K
Relative Volume:
0.27
Capitalizzazione di mercato:
$17.55B
Reddito:
$2.90B
Utile/perdita netta:
$467.20M
Rapporto P/E:
38.29
EPS:
6.37
Flusso di cassa netto:
$306.90M
1 W Prestazione:
+2.82%
1M Prestazione:
+7.39%
6M Prestazione:
+22.53%
1 anno Prestazione:
-17.42%
Intervallo 1D:
$239.25
$244.19
Intervallo di 1 settimana:
$237.18
$250.38
Portata 52W:
$187.43
$352.33
West Pharmaceutical Services Inc Stock (WST) Company Profile
Nome
West Pharmaceutical Services Inc
Settore
Industria
Telefono
(610) 594-2900
Indirizzo
530 HERMAN O. WEST DRIVE, EXTON, PA
Confronta WST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
244.01 | 17.28B | 2.90B | 467.20M | 306.90M | 6.37 |
|
ISRG
Intuitive Surgical Inc
|
481.21 | 169.15B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
194.56 | 55.18B | 21.39B | 1.59B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
289.44 | 41.63B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
86.54 | 41.88B | 9.93B | 1.12B | 1.58B | 2.25 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-24 | Iniziato | Barclays | Equal Weight |
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Iniziato | Citigroup | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-12 | Aggiornamento | UBS | Neutral → Buy |
| 2024-02-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-04-11 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-11-30 | Iniziato | UBS | Neutral |
| 2022-10-28 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Iniziato | Stephens | Equal-Weight |
| 2020-07-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-04-24 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Downgrade | Jefferies | Buy → Hold |
| 2019-04-23 | Iniziato | William Blair | Outperform |
| 2018-04-25 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Iniziato | Goldman | Neutral |
| 2017-10-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Iniziato | Stephens | Equal-Weight |
| 2017-09-15 | Aggiornamento | Jefferies | Hold → Buy |
| 2016-10-28 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Iniziato | Wells Fargo | Outperform |
| 2010-05-14 | Reiterato | UBS | Neutral |
| 2010-02-23 | Iniziato | Jefferies & Co | Buy |
| 2008-12-19 | Iniziato | UBS | Neutral |
Mostra tutto
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical Services and The Cooper Companies - The Globe and Mail
CAH Q4 Earnings Beat Estimates, '26 EPS View Up, Stock Falls - TradingView
West Pharmaceutical Services, Inc. shares rise 1.24% premarket due to projected growth in Sterilization Medical Packaging Market. - AInvest
Stock Analysis | West Pharmaceutical OutlookA Stock Poised to Watch Closely - AInvest
BofA Securities Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Raises Target Price to $310 - 富途牛牛
MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View - TradingView
The Best Healthcare Stocks to Buy - Morningstar
Chart Patterns Forming a Bullish Setup in West Pharmaceutical Services Inc.Low Risk Equity Screener With Results Shared - metal.it
What makes West Pharmaceutical Services Inc. stock price move sharplyTriple-digit returns - Jammu Links News
What are analysts’ price targets for West Pharmaceutical Services Inc. in the next 12 monthsBuild a portfolio that outperforms the market - Jammu Links News
How does West Pharmaceutical Services Inc. compare to its industry peersBreakout stock performance - Jammu Links News
What catalysts could drive West Pharmaceutical Services Inc. stock higher in 2025Record-breaking capital gains - Jammu Links News
When is West Pharmaceutical Services Inc. stock expected to show significant growthDynamic investment opportunities - Jammu Links News
What analysts say about West Pharmaceutical Services Inc. stockBuild wealth faster with expert stock picks - Jammu Links News
Is it the right time to buy West Pharmaceutical Services Inc. stockMaximize gains with data-driven trading alerts - Jammu Links News
Is West Pharmaceutical Services Inc. stock overvalued or undervaluedAchieve consistent profits with proven methods - Jammu Links News
How strong is West Pharmaceutical Services Inc. company’s balance sheetOver 200% growth - Jammu Links News
How volatile is West Pharmaceutical Services Inc. stock compared to the marketUnlock powerful trading tools for investors - Jammu Links News
Why is West Pharmaceutical Services Inc. stock attracting strong analyst attentionDiscover market opportunities with real-time data - Jammu Links News
West Pharmaceutical Lifts Full-Year Forecast After Strong Q2 Performance - MSN
What is the dividend policy of West Pharmaceutical Services Inc. stockTop Growth Tracker With Low Risk - Jammu Links News
How many analysts rate West Pharmaceutical Services Inc. as a “Buy”Post Market Growth Plan To Watch Now - Jammu Links News
West Pharmaceutical Services Exceeds Expectations Amidst Rising HVP DemandNews and Statistics - IndexBox
Will West Pharmaceutical Services Inc. stock recover after recent dropConservative Entry for High Return Setup Backed - metal.it
West Pharmaceutical Services: A Strategic Buy in the HVP and Biologics Boom? - AInvest
The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q2 Earnings Call - Yahoo Finance
GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises - TradingView
Intrinsic Value of West Pharmaceutical Services Inc. Stock: Is It Undervalued or OvervaluedEarly Entry Tips With Low Risk Zone Shared - metal.it
West Pharmaceutical: Q2 Earnings Suggest Recovery (NYSE:WST) - Seeking Alpha
Wall Street Analysts Think West Pharmaceutical (WST) Could Surge 25.26%: Read This Before Placing a Bet - Zacks Investment Research
Published on: 2025-07-29 21:00:13 - metal.it
Published on: 2025-07-29 18:40:03 - metal.it
How does West Pharmaceutical Services Inc. generate profit in a changing economyDaily Trading Ideas For Fast Growth - Jammu Links News
Are Bears Losing Grip on West Pharmaceutical Services Inc.AI Driven Buy Alert Trade Blueprint Released - metal.it
Published on: 2025-07-29 09:09:27 - metal.it
Will West Pharma's Revised Guidance Drive The Stock North? - RTTNews
Will Volume Confirm Reversal in West Pharmaceutical Services Inc.Conservative Long Term Growth Plans Under Review - metal.it
West Pharmaceutical Services To Go Ex-Dividend On July 30th, 2025 With 0.21 USD Dividend Per Share - 富途牛牛
West Pharmaceutical Services Stock (WST) Opinions on Q2 Earnings Beat - Quiver Quantitative
What are the technical indicators suggesting about West Pharmaceutical Services Inc.Market Forecast Target Finder For 2025 - Jammu Links News
West Pharmaceutical (WST) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Upcoming Dividend Payments: Constellation Brands, Conagra Brands, and West Pharmaceutical Services - AInvest
Ex-Dividend Reminder: Constellation Brands, Conagra Brands and West Pharmaceutical Services - Nasdaq
Does West Pharmaceutical Services Inc. stock perform well during market downturnsBreakthrough capital growth - Jammu Links News
West Pharmaceutical Services Inc Azioni (WST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):